Mechanisms of Osimertinib Resistance in EGFR Mutant Lung Cancer

被引：0
|
作者：
Westover, D. [1 ]
Qiao, H. [1 ]
Ichihara, E. [1 ]
Meador, C. B. [1 ]
Lovly, C. M. [1 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 08期
关键词：
D O I：
10.1016/j.jtho.2017.06.063
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1546 / S1546
页数：1
相关论文
共 50 条
  • [1] Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung Cancer
    Roper, Nitin
    Brown, Anna-Leigh
    Wei, Jun S.
    Pack, Svetlana
    Trindade, Christopher
    Kim, Chul
    Restifo, Olivia
    Gao, Shaojian
    Sindiri, Sivasish
    Mehrabadi, Farid
    El Meskini, Rajaa
    Ohler, Zoe Weaver
    Maity, Tapan K.
    Venugopalan, Abhilash
    Cultraro, Constance M.
    Akoth, Elizabeth
    Padiernos, Emerson
    Chen, Haobin
    Kesarwala, Aparna
    Smart, DeeDee K.
    Nilubol, Naris
    Rajan, Arun
    Piotrowska, Zofia
    Xi, Liqiang
    Raffeld, Mark
    Panchenko, Anna R.
    Sahinalp, Cenk
    Hewitt, Stephen
    Hoang, Chuong D.
    Khan, Javed
    Guha, Udayan
    CELL REPORTS MEDICINE, 2020, 1 (01)
  • [2] Mechanisms of resistance for osimertinib for patients with EGFR-mutant lung cancer: MD Anderson Cancer Center single institution experience with osimertinib resistance
    Le, Xiuning
    Negrao, Marcelo Vailati
    Nilsson, Monique
    Robichaux, Jacqulyne
    Roarty, Emily
    Rinsurongkawong, Waree
    Glisson, Bonnie
    Zhang, Jianjun
    Heymach, John V.
    CANCER RESEARCH, 2018, 78 (13)
  • [3] Combatting acquired resistance to osimertinib in EGFR-mutant lung cancer
    Lee, Jiyun
    Piotrowska, Zofia
    Soo, Ross
    Cho, Byoung Chul
    Lim, Sun Min
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [4] ALK rearrangements as mechanisms of acquired resistance to osimertinib in EGFR mutant non-small cell lung cancer
    Hou, Helei
    Sun, Dantong
    Zhang, Chuantao
    Liu, Dong
    Zhang, Xiaochun
    THORACIC CANCER, 2021, 12 (06) : 962 - 969
  • [5] Effect of P. gingivalis on osimertinib resistance in EGFR-mutant lung cancer
    Li, Wendong
    Rotter-Maskowitz, Aviva
    Zhang, Keqiang
    Massarelli, Erminia
    Potempa, Jan
    Straussman, Ravid
    Raz, Dan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Acquired ALK and RET Gene Fusions as Mechanisms of Resistance to Osimertinib in EGFR-Mutant Lung Cancers
    Offin, Michael
    Somwar, Romel
    Rekhtman, Natasha
    Benayed, Ryma
    Chang, Jason C.
    Plodkowski, Andrew
    Lui, Allan J. W.
    Eng, Juliana
    Rosenblum, Marc
    Li, Bob T.
    Riely, Gregory J.
    Rudin, Charles M.
    Kris, Mark G.
    Travis, William
    Drilon, Alexander
    Arcila, Maria E.
    Ladanyi, Marc
    Yu, Helena A.
    JCO PRECISION ONCOLOGY, 2018, 2 : 1 - 12
  • [7] Tackling Osimertinib Resistance in EGFR-Mutant Non-Small Cell Lung Cancer
    Blaquier, Juan Bautista
    Ortiz-Cuaran, Sandra
    Ricciuti, Biagio
    Mezquita, Laura
    Cardona, Andres Felipe
    Recondo, Gonzalo
    CLINICAL CANCER RESEARCH, 2023, 29 (18) : 3579 - 3591
  • [8] Brain metastatic outgrowth and osimertinib resistance are potentiated by RhoA in EGFR-mutant lung cancer
    Adua, Sally J.
    Arnal-Estape, Anna
    Zhao, Minghui
    Qi, Bowen
    Liu, Zongzhi Z.
    Kravitz, Carolyn
    Hulme, Heather
    Strittmatter, Nicole
    Lopez-Giraldez, Francesc
    Chande, Sampada
    Albert, Alexandra E.
    Melnick, Mary-Ann
    Hu, Bomiao
    Politi, Katerina
    Chiang, Veronica
    Colclough, Nicola
    Goodwin, Richard J. A.
    Cross, Darren
    Smith, Paul
    Nguyen, Don X.
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [9] Brain metastatic outgrowth and osimertinib resistance are potentiated by RhoA in EGFR-mutant lung cancer
    Sally J. Adua
    Anna Arnal-Estapé
    Minghui Zhao
    Bowen Qi
    Zongzhi Z. Liu
    Carolyn Kravitz
    Heather Hulme
    Nicole Strittmatter
    Francesc López-Giráldez
    Sampada Chande
    Alexandra E. Albert
    Mary-Ann Melnick
    Bomiao Hu
    Katerina Politi
    Veronica Chiang
    Nicola Colclough
    Richard J. A. Goodwin
    Darren Cross
    Paul Smith
    Don X. Nguyen
    Nature Communications, 13
  • [10] How to overcome and circumvent acquired resistance to osimertinib or lazertinib in advanced EGFR mutant lung cancer?
    Cho, Byoung Chul
    ANNALS OF ONCOLOGY, 2023, 34 : S1378 - S1378
12345